← FDA Drug Approvals (Drugs@FDA)

ZANVASTRO

NDA · New Drug Application · Sponsor: IONIS PHARMS INC · Approved 2026-09-03

Drug application

FDA Application #

NDA220210

Application type

New Drug Application

Brand name

ZANVASTRO

Generic name

Zilganersen Sodium

Active ingredients

ZILGANERSEN SODIUM

Dosage form

SOLUTION

Route

INTRATHECAL

Marketing status

Prescription

Sponsor

IONIS PHARMS INC

First approval

2026-09-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown